ArticleJCO global oncology2022
Geographic Distribution of Cancer Care Providers in the Philippines.
Article in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- A Health Systems Analysis of Global Head and Neck Cancer Outcomes.The Laryngoscope · 2026Article
- Geographic barriers to gynaecological cancer care in Indonesia: a geospatial and infrastructure analysis.BMJ open · 2026Article
- Milestones and Horizons: Highlights from the 4th International Children's Palliative Care Network Conference in Manila, Philippines.Ecancermedicalscience · 2026Article
- Global determinants of cervical cancer outcomes: a health systems analysis.BMJ oncology · 2026Article
- Personalised neoantigen vaccines for precision oncology in Southeast Asia: clinical opportunities, infrastructure challenges, and policy perspectives.Frontiers in immunology · 2026Review
- The Burden of Genitourinary Malignancies in Southeast Asia from 1990 to 2021.European urology oncology · 2025Article
- Cancer survivorship in the Western Pacific: from differences to shared-goals and from challenges to opportunities.The Lancet regional health. Western Pacific · 2025Review
- Barriers to Immune Checkpoint Inhibitor Access for Patients With Cancer in Southeast Asia: Challenges and Policy Implications.JCO global oncology · 2025Article
- Burden of prolonged treatment delay among patients with common cancers in the Philippines.Cancer causes & control : CCC · 2025Article
- Radiotherapy medical physics in the Philippines: A contemporary overview.Journal of applied clinical medical physics · 2025Article
- Travel Burden of Radiation Therapy in the Philippines.Advances in radiation oncology · 2025Article
- Establishing the Philippine Cancer Center National Cancer Research Agenda 2024-2028: Insights and Future Directions.JCO global oncology · 2025Article
- Identifying Gaps in Early-Onset Colorectal Cancer Prevention, Screening, and Treatment in the Philippines.Annals of surgical oncology · 2024Article
- Radiotherapy services in the Philippines: exploring geographical barriers to improve access to care.The Lancet regional health. Western Pacific · 2024Article
- Article
- Cancer disparities in Southeast Asia: intersectionality and a call to action.The Lancet regional health. Western Pacific · 2023Article
- Leveraging national and global political determinants of health to promote equity in cancer care.Journal of the National Cancer Institute · 2023Article
- To Chemo or Not to Chemo… That Is the Question.JCO global oncology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeIn the Philippines, a lower middle-income country in Southeast Asia, 6 of 10 Filipinos die without seeing a doctor. To ensure universal access to cancer care, providers must be equitably distributed. Therefore, we evaluated the distribution of oncologists across all 17 regions in the Philippines.
methodsWe gathered data from the official websites of national medical societies on their members' regional area of practice: Philippine Society of Medical Oncology, Philippine Radiation Oncology Society, Surgical Oncology Society of the Philippines, Society of Gynecologic Oncologists of the Philippines, and Philippine Society of Hospice and Palliative Medicine. We compared this with the regional census to determine the number of board-certified oncologists per 100,000 Filipinos.
resultsFor a population of almost 110 million, the Philippines has a total of 348 medical oncologists, 164 surgical oncologists, 99 radiation oncologists, 142 gynecologic oncologists, and 35 hospice and palliative medicine (HPM) specialists. This translates to 0.32 medical oncologists, 0.15 surgical oncologists, 0.09 radiation oncologists, 0.13 gynecologic oncologists, and 0.03 HPM specialists for every 100,000 Filipinos. The number of oncologists is highest in the National Capital Region in Luzon and lowest in the Bangsamoro Autonomous Region in Muslim Mindanao. All regions have at least one medical and gynecologic oncologist. Two regions (12%) have no surgical oncologists, five regions (29%) have no radiation oncologists, and eight regions (47%) have no HPM specialists.
conclusionEfforts are needed to increase the number of oncologists and improve equity in their distribution to ensure universal access to cancer care in the Philippines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.